Originally published via Armageddon Prose:

Since September of last year, a team of Danish researchers, backed by $1.6 million in funding from RFK Jr.'s CDC, had planned a large-scale hepatitis B vaccine trial in the sub-Saharan African nation of Guinea-Bissau.

Per the study design, the control group of 7,000 infants would skip the at-birth hepatitis B vaccine dose and receive it later on at six weeks, whereas the experimental group of 7,000 infants would receive the shot immediately at birth, the objective being to assess potential adverse health impacts of the hepatitis B shot in day-old infants — a practice which the Public Health™ experts stateside have gone to war to shield from scrutiny, notwithstanding the facts that:

· Screening mothers for hepatitis B is cheap and easy

· Hepatitis B, outside of mother-to-infant transmission, is nearly exclusively acquired via unprotected sex and intravenous drug use, neither of which most rational people outside of Portland or Brooklyn would recognize as normal activities for infants

The World Health Organization (WHO), which relies heavily on funding from the likes of vaxx overlord Bill Gates, came out swinging in February against the proposal.

Via World Health Organization, February 13, 2026:

"The World Health Organization (WHO) underscores that the hepatitis B birth dose vaccine is an effective, and essential public health intervention, with a proven record…

WHO is aware of the proposed randomized controlled trial (RCT) on the hepatitis B birth dose vaccine in Guinea?Bissau. Based on questions raised in publicly available information and consultation with relevant experts, WHO has significant concerns regarding the study's scientific justification, ethical safeguards, and overall alignment with established principles for research involving human participants…

Placebo or no?treatment vaccine trials are only acceptable when no proven intervention exists or when such a design is indispensable to answer a critical question of efficacy or safety. Neither condition appears to be met based on publicly available descriptions of the study…